Skip to content

Exor N.V.

Follow

13F filer, CIK 1589122, Amsterdam, Netherlands

Exor N.V. reported $5,457,023,943 across 3 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-03.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-329704

Period
2026-06-30
Reported value
$5.46B
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
0added+3,388,714$92.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001193125-26-329704, largest first. % of portfolio is the value over $5,457,023,943, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 164,553,857 shares; 2024Q4: 164,553,857 shares; 2025Q1: 172,779,520 shares; 2025Q2: 182,543,970 shares; 2025Q3: 182,543,970 shares; 2025Q4: 182,543,970 shares; 2026Q1: 182,543,970 shares; 2026Q2: 185,932,684 shares 185,932,684$5.06B92.64%+3,388,714
VIAVIA TRANSN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,121,131 shares; 2025Q4: 14,121,131 shares; 2026Q1: 14,121,131 shares; 2026Q2: 14,121,131 shares 14,121,131$256M4.69%0Timeline
CLVTCLARIVATE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 67,294,884 shares; 2024Q4: 67,294,884 shares; 2025Q1: 67,294,884 shares; 2025Q2: 67,294,884 shares; 2025Q3: 67,294,884 shares; 2025Q4: 67,294,884 shares; 2026Q1: 67,294,884 shares; 2026Q2: 67,294,884 shares 67,294,884$145M2.66%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-329704 base2026-08-03acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001193125-26-329704 Quarter ended 2026-06-302026-08-03acceptance time not in the bulk data set
13F-HR 0001193125-26-220683 Quarter ended 2026-03-312026-05-13acceptance time not in the bulk data set
13F-HR 0001193125-26-035487 Quarter ended 2025-12-312026-02-03acceptance time not in the bulk data set
13F-HR 0001193125-25-276224 Quarter ended 2025-09-302025-11-12acceptance time not in the bulk data set
13F-HR 0000950123-25-006414 Quarter ended 2025-06-302025-07-16acceptance time not in the bulk data set
13F-HR 0000950123-25-004315 Quarter ended 2025-03-312025-05-08acceptance time not in the bulk data set
13F-HR 0000950123-25-000464 Quarter ended 2024-12-312025-01-22acceptance time not in the bulk data set
13F-HR 0000950123-24-009747 Quarter ended 2024-09-302024-10-17acceptance time not in the bulk data set
13F-HR 0000950123-24-006433 Quarter ended 2024-06-302024-07-09acceptance time not in the bulk data set
13F-HR 0000950123-24-003340 Quarter ended 2024-03-312024-04-16acceptance time not in the bulk data set
13F-HR 0000950123-24-001441 Quarter ended 2023-12-312024-02-12acceptance time not in the bulk data set
13F-HR 0000950123-23-009644 Quarter ended 2023-09-302023-11-08acceptance time not in the bulk data set
13F-HR 0000950123-23-007956 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0000950123-23-005195 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0000950123-23-002347 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-NT 0001589122-18-000002 Quarter ended 2018-03-312018-04-17acceptance time not in the bulk data set
13F-NT 0001589122-18-000001 Quarter ended 2017-12-312018-03-14acceptance time not in the bulk data set